BRIEF published on 04/30/2024 at 22:35, 11 months 6 days ago CROSSWOOD 2023 annual results Financial Results Real Estate Dividend Debt CROSSWOOD
PRESS RELEASE published on 04/30/2024 at 22:30, 11 months 6 days ago Résultats annuels 2023 Le Conseil d'Administration de la Société CROSSWOOD arrête les comptes annuels 2023, avec un patrimoine global de 97,8 M€ et un ANR de liquidation à 7,45 €. Résultat net 2023 de -1,8 M€. Structure financière solide avec un dividende proposé de 0,10 € par action Dividende Résultat Net Comptes Annuels Patrimoine CROSSWOOD
Published on 04/07/2025 at 00:05, 7 hours 32 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 07:03, 34 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 37 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/06/2025 at 18:20, 13 hours 17 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 16 hours 28 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 12 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/07/2025 at 07:01, 36 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 36 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 13 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
